Scarica l'app Stockscreener
29.32
2.27%
-0.68
Dopo l'orario di chiusura:
29.32
Precedente Chiudi:
$30.00
Aprire:
$30.57
Volume 24 ore:
645.98K
Relative Volume:
1.47
Capitalizzazione di mercato:
$344.61M
Reddito:
$7.49M
Utile/perdita netta:
$-360.50M
Rapporto P/E:
-0.7095
EPS:
-41.3227
Flusso di cassa netto:
$-33.68M
1 W Prestazione:
-0.74%
1M Prestazione:
+29.73%
6M Prestazione:
+5.20%
1 anno Prestazione:
+112.93%
Intervallo 1D:
$28.93
$30.68
Intervallo di 1 settimana:
$28.93
$33.38
Portata 52W:
$11.39
$37.83
Surrozen Inc Stock (SRZN) Company Profile
Nome
Surrozen Inc
Settore
Industria
Telefono
650-475-2820
Indirizzo
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN vs VRTX, MRNA, REGN, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
29.32 | 347.20M | 7.49M | -360.50M | -33.68M | -41.32 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-21 | Iniziato | TD Cowen | Buy |
| 2026-02-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-30 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-03 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-09-15 | Iniziato | Guggenheim | Buy |
| 2021-09-07 | Iniziato | Stifel | Buy |
Mostra tutto
Surrozen Inc Borsa (SRZN) Ultime notizie
Commodore Capital reports a passive stake above 5% in Surrozen (SRZN). - Stock Titan
LifeSci Capital Maintains Surrozen(SRZN.US) With Buy Rating, Maintains Target Price $54 - Moomoo
Surrozen Is Maintained at Buy by HC Wainwright & Co. - Moomoo
Surrozen Price Target Raised to $54.00/Share From $44.00 by HC Wainwright & Co. - Moomoo
Two new option listings and eight option delistings on September 21st - TipRanks
H.C. Wainwright raises Surrozen stock price target on Wnt pathway validation By Investing.com - Investing.com South Africa
H.C. Wainwright raises Surrozen stock price target on Wnt pathway validation - Investing.com
Scholastic Posts Downbeat Q1 Results, Joins Legacy Education, Zscaler And Other Big Stocks Moving Lower I - Benzinga
(SRZN) Risk Channels and Responsive Allocation - Stock Traders Daily
DME red flag in Merck Brunello phase III? Surrozen finishes rich - BioWorld News
SRZN Price Today: Surrozen, Inc. Stock Price, Quote & Chart | MEXC - MEXC
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Top Biotech Stocks To Keep An Eye OnSeptember 24th - MarketBeat
Crude Oil Rises Over 4%; Darden Earnings Miss Views - benzinga.com
Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy - Benzinga
Surrozen (SRZN) stock doubles as traders focus on IND progress and potential financing milestone - Quiver Quantitative
SRZN Options Volatility — NASDAQ:SRZN - TradingView
SRZN Options Chain — NASDAQ:SRZN - TradingView
Surrozen, Inc.(NasdaqCM: SRZN) added to S&P Global BMI Index - marketscreener.com
Surrozen at Morgan Stanley conference: eyeing dual-action edge - Investing.com
Surrozen at Morgan Stanley conference: eyeing dual-action edge By Investing.com - Investing.com Canada
(SRZN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Surrozen submits IND to FDA for DME therapeutic - Glance by Eyes On Eyecare
Surrozen at Cantor healthcare conference: eye drug strategy takes shape - Investing.com
Surrozen at Cantor healthcare conference: eye drug strategy takes shape By Investing.com - Investing.com Canada
Guggenheim Names Top Biotechnology Stock Pick By Investing.com - Investing.com India
Surrozen files SZN-8141 IND application for DME - BioWorld News
Guggenheim Names Top Biotechnology Stock Pick - Investing.com
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema - markets.businessinsider.com
Surrozen Files Investigational New Drug Application for SZN-8141 in Diabetic Macular Edema - marketscreener.com
One drug combines two approaches for diabetic vision loss. Surrozen submitted an application to the FDA. - Stock Titan
Surrozen Inc. Warrant (SRZNW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Discipline and Rules-Based Execution in SRZN Response - Stock Traders Daily
Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewswire
Surrozen Inc. Warrant (SRZNW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Surrozen Inc. Warrant (SRZNW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Surrozen Inc. Warrant (SRZNW) Peer Comparison – Compare with Others - Value Research
William Blair Upgrades Surrozen (NASDAQ:SRZN) to "Strong-Buy" - MarketBeat
William Blair Initiates Surrozen at Outperform - marketscreener.com
William Blair initiates Surrozen stock with Outperform rating By Investing.com - Investing.com Canada
William Blair initiates Surrozen stock with Outperform rating - Investing.com
Surrozen (SRZN) Q2 2026 Results: Profit Per Share Clears Its Benchmark on the Day; Market Reaction - vinanet.vn
Guggenheim Names Top Stock Pick in Biotech Sector By Investing.com - Investing.com Nigeria
LifeSci Capital Maintains Surrozen(SRZN.US) With Buy Rating, Maintains Target Price $46 - Moomoo
SRZN Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers Strong Beat as Stage Remains Pre-Revenue - vinanet.vn
Braidwell group reports 3.9% Surrozen (SRZN) holding in amended 13G filing - Stock Titan
Surrozen (SRZN): Boxer Capital group discloses 8.9% ownership stake in 13G/A - Stock Titan
Liquidity Mapping Around (SRZN) Price Events - Stock Traders Daily
StemPoint Capital reports 5.0% Surrozen (SRZN) stake via shares and warrants - Stock Titan
Analysts Just Made A Massive Upgrade To Their Surrozen, Inc. (NASDAQ:SRZN) Forecasts - simplywall.st
What is HC Wainwright's Estimate for Surrozen Q3 Earnings? - MarketBeat
Surrozen Inc Azioni (SRZN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Surrozen Inc Azioni (SRZN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Li Yang | Exec. Vice President, Research |
May 04 '26 |
Sale |
33.33 |
1,584 |
52,799 |
17,216 |
| Williams Charles O | Chief Operating Officer |
May 04 '26 |
Sale |
33.33 |
2,036 |
67,866 |
16,571 |
| Parker Craig C | Chief Executive Officer |
May 04 '26 |
Sale |
33.33 |
4,524 |
150,798 |
16,553 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 24 '26 |
Buy |
24.69 |
106,658 |
2,633,717 |
736,554 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 23 '26 |
Buy |
24.90 |
15,223 |
379,051 |
683,225 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 13 '26 |
Buy |
24.88 |
35,433 |
881,463 |
675,018 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 12 '26 |
Buy |
24.99 |
12,374 |
309,166 |
657,301 |
| TCG Crossover GP II, LLC | 10% Owner |
Mar 16 '26 |
Buy |
24.99 |
1,190 |
29,733 |
675,613 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 11 '26 |
Buy |
23.57 |
17,763 |
418,763 |
650,567 |
| TCG Crossover GP II, LLC | 10% Owner |
Feb 12 '26 |
Buy |
23.86 |
1,093 |
26,082 |
651,114 |
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):